Best Practices for AI IP Strategies

In 2025 we expect several key trends to shape the private equity landscape, including the evolution of continuation vehicles, heightened regulatory pressure and antitrust scrutiny, interest rate cuts, and risk tolerance discrepancy between buyers and sellers. Private Equity Co-chairs Gregory Fine, Kurt Steinkrauss, and Matthew T. Simpson, and Investment Funds Practice Chair Kari Harris, provide insights on these trends to help business owners navigate a more complex deal environment.

An optimal structure is essential for life science companies looking to maximize cross-border opportunities. In their article for BIOTECanada’s Insights Magazine, International Chair of Life Sciences Cheryl Reicin and Associate Luke Jeagal offer valuable guidance on determining which entity should hold intellectual property, hire employees, and serve as the parent or subsidiary.

With former President Trump as the President-Elect, policy changes are anticipated across the regulatory and legislative landscape. Mintz and ML Strategies are providing guidance for businesses navigating these shifts across a wide range of industries including those impacted by cross-border regulations.

Mintz represented the US Department of Energy’s Loan Programs Office in its conditional commitment for a loan guarantee of up to $1.44 billion to Montana Renewables, LLC. Montana Renewables is an unrestricted subsidiary of Calumet (NASDAQ: CLMT). The deal team was led by Project Development & Finance Chair Ayaz Shaikh, Paul Dickerson, Kris Kirkwood, and Lyndon Plothow.

The Ninth Circuit’s ruling that facial signatures in “tag suggestion” technology aren’t biometric identifiers under BIPA marks a major win for tech companies. Privacy & Cybersecurity Co-chair Scott Lashway and Special Counsel Matthew MK Stein examine the guidance this ruling offers for technology companies navigating biometric data risks and the precedent it sets for managing privacy as facial recognition technology advances.